您现在的位置: 首页> 研究主题> 体部伽玛刀

体部伽玛刀

体部伽玛刀的相关文献在2001年到2022年内共计173篇,主要集中在肿瘤学、临床医学、特种医学 等领域,其中期刊论文145篇、会议论文24篇、专利文献593645篇;相关期刊98种,包括世界中医药、临床医学、临床肿瘤学杂志等; 相关会议13种,包括北京放射肿瘤学术论坛、武警部队放射专业委员会第八届放射学术会议 、江西省中医药学会2011年学术年会等;体部伽玛刀的相关文献由423位作者贡献,包括康静波、李建国、朱奇等。

体部伽玛刀—发文量

期刊论文>

论文:145 占比:0.02%

会议论文>

论文:24 占比:0.00%

专利文献>

论文:593645 占比:99.97%

总计:593814篇

体部伽玛刀—发文趋势图

体部伽玛刀

-研究学者

  • 康静波
  • 李建国
  • 朱奇
  • 齐文杰
  • 聂青
  • 张丽萍
  • 单国用
  • 董桂云
  • 李启亮
  • 苏加利
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 于真懿
    • 摘要: 目的:分析癌性上腔静脉综合征疾病患者行体部伽玛刀与化疗姑息联合治疗的可行性和临床效果。方法:选择本院2018年10月~2019年10月的癌性上腔静脉综合征患者86例。经医院伦理委员会批准同意,患者与家属知情同意,予以患者体部伽玛刀联合化疗姑息治疗,比较治疗后不同癌性上腔静脉综合征患者治疗效果以及患者满意度情况。结果:治疗后,不同类型癌性上腔静脉综合征患者近期治疗效果比较,小细胞肺癌总有效率为100.00%、非小细胞肺癌总有效率为91.30%、食管癌纵隔淋巴结转移总有效率为100.00%、恶性淋巴瘤总有效率为100.00%。经统计学计算,无显著性差异,P>0.05。进行患者治疗效果满意度问卷调查,小细胞肺癌、非小细胞肺癌、食管癌纵隔淋巴结转移、恶性淋巴瘤疾病患者满意度接近。经统计学计算,无显著性差异,P>0.05。结论:癌性上腔静脉综合征疾病患者行体部伽玛刀联合化疗姑息治疗近期效果显著,患者耐受性状况良好,是有效的治疗手段,满足患者治疗需求。
    • 杜海峰; 卞晓山
    • 摘要: 目的:探讨立体定向体部放射治疗(SBRT)联合肝动脉介入栓塞化疗(TACE)治疗不能手术的原发性肝癌伴门静脉癌栓的临床疗效。方法:2012年11月至2018年9月原发性肝癌伴门静脉癌栓患者62例均采用体部伽玛刀联合TACE治疗,TACE 1~2次,体部伽玛刀局部照射癌栓4~9 Gy/次,隔日治疗5~10次,总剂量35~54 Gy (中位38 Gy)。结果:全部患者均完成治疗。10例(16.1%)癌栓完全缓解,21例(33.9%)部分缓解,25例(40.3%)稳定,6例(9.7%)进展,总有效率(CR + PR + NC) 56例(90.3%);1、2和3年生存率分别为30.6%、16.1%和3.2%,中位生存期12.8个月。结论:SBRT联合TACE治疗原发性肝癌伴门静脉癌栓有效提高了患者生存质量,延长了生存期。
    • 容谦; 刘兴安; 单国用
    • 摘要: 目的 探讨体部伽玛刀联合化疗姑息疗法治疗癌性上腔静脉综合征的临床效果.方法 选取2017年2月至2018年8月在郑州人民医院治疗的癌性上腔静脉综合征患者92例为研究对象,给予所有患者体部伽玛刀联合化疗姑息治疗处理,治疗一周期后应继续化疗4个周期.观察、记录患者的临床治疗结局.结果 92例患者中不存在病情发展情形,即临床诊治有效性为97.83%(90/92).对放疗敏感度较低的非小细胞癌患者也获得理想的近期疗效.结论 在癌性上腔静脉综合征患者的临床治疗过程中应用体部伽玛刀联合化疗姑息疗法进行治疗,诊治结局甚佳,能够有效缓解患者的临床症状,提升临床治愈率,增强患者的耐受性,同时有助于降低不良反应的发生率及疾病复发率,临床应用价值十分理想.
    • 王桂林; 周小宝
    • 摘要: 目的 探讨立体定向放射(体部伽玛刀)治疗原发性肝癌的疗效.方法 选取本院2015年1月至2018年12月期间收治,179例原发性肝癌患者作为资料,均采用立体定向体部伽玛射线放射治疗系统治疗,评价近期疗效.结果 立体定向放射治疗有效率为70.48%,其中术后放疗84.48%,介入后放疗72.88%,单纯放疗为54.83%;肿瘤最大直径<5cm有效率79.63%,5-10 cm为67.79%,≥10 cm为48.48%;放疗后并发症发生率16.80%.结论 在原发性肝癌治疗中应用立体定向体部伽玛射线放射治疗系统可获得良好的近期效果,且肿瘤越小治疗效果越明显,配合手术治疗及介入治疗可进一步提高疗效,而且未发生严重放射性并发症,安全性高,值得推广.
    • 蔡薇薇; 苏加利; 杨妤; 朱道奇; 刘利民; 黄高明
    • 摘要: 目的:探讨肝动脉化疗栓塞术(trashepatic arterial chemotherapy and embolization,TACE)联合体部伽玛刀治疗巨块型原发性肝癌的疗效及毒副反应.方法:对38例非手术治疗的巨块型肝癌患者行TACE联合体部伽玛刀治疗,伽玛刀治疗结束后4周行肝脏CT或MRI检查评价疗效,以后定期随访复查.结果:近期疗效:完全缓解(CR)0例,部分缓解(PR)23例,稳定(SD)12例,进展(PD)3例,近期总有效率(RR) 92.1%.1、3、5年生存率分别为81.6%、10.5%、5.3%.主要毒副反应为消化道反应、骨髓抑制及放射性肝炎,患者均能耐受.结论:TACE联合体部伽玛刀治疗巨块型肝癌的效果好,毒副反应较轻.%Objective:To evaluate the clinical efficacy and side reactions of TACE combined with body gamma knife radiotherapy for patients with huge hepatocellular carcinoma.Methods:38 cases of non-surgical treatment of huge hepatocellular carcinoma patients were treatment by TACE combined with body gamma knife radiotherapy.4 weeks after gamma knife treatment,hepatic CT or MRI examinations were performed to evaluate the efficacy.All patients were followed up and reexamined regularly.Results:Short-term effictive:complete remission in 0 cases,partial remission in 23 cases,stable disease in 12 cases,progress disease in 3 cases,and the short-term effective rate was 92.1%.The 1,3 and 5 years survival rate was 81.6%,10.5% and 5.3% respectively.The main adverse events were digestive tract reaction,myelosuppression and radioactive hepatitis.All of the patients were tolerable.Conclusion:TACE combined with body gamma knife radiotherapy for the treatment of patients with huge hepatocellular carcinoma has good effect with mild side reactions.
    • 苏琳; 苏加利; 蔡薇薇
    • 摘要: 目的:探讨肺腺癌患者胸苷酸合成酶(TS)不同表达水平与放射敏感性的关系.方法:对经病理确诊的94例局部晚期肺腺癌患者,根据TS不同表达水平,将患者分为高表达组(40例)和低表达组(54例).对患者的肺部原发病灶行体部伽玛刀立体定向适形放射治疗,放疗结束后1个月复查胸部CT评价近期疗效.结果:全部患者均按计划完成治疗,两组近期疗效:高表达组:CR 3例,PR 27例,SD 7例,PD 3例,近期总有效率为75.0%[(CR+PR)/总病例数 ×100%];低表达组:CR 8例,PR 41例,SD 3例,PD 2例,近期总有效率为90.7%.两组近期疗效比较差异有统计学意义(P<0.05).结论:肺腺癌TS低表达组的放疗后近期疗效好,提示TS表达水平可能作为肺腺癌放射敏感性的标志物之一.
    • 骆锦添
    • 摘要: 近年来,图像引导技术获得了越来越广泛的应用,其具有定位精确,成像时间短等特点,已逐渐发展为现代精确放射治疗的重要基础.而体部伽玛刀是我国结合国外头部伽玛刀技术研发而来的新型放疗设备,在多年的临床应用中,一直受限于较为传统的体部框架定位技术.通过将图像引导定位技术运用于体部伽玛刀,将进一步促进体部伽玛刀SBRT的规范治疗.本文对体部伽玛刀图像引导技术的原理及应用展开研究.
    • 袁继龙; 程金生; 刘立明; 苏旭
    • 摘要: 目的:在同一蒙特卡罗(MC)模拟平台上,对不同型号的动态旋转体部伽玛刀辐射剂量学进行MC模拟研究.方法:①根据体部伽玛刀聚焦照射模式,选择代表机型,即OUR-QGD型体部伽玛刀和LUNA全身伽玛刀;②基于EGSnrc分别进行MC建模;③利用EBT3胶片和160 mm有机玻璃球模体测量焦点处剂量分布进行MC模型验证;④利用验证的模型进行剂量学研究.结果:OUR-QGD型体部伽玛刀和LUNA全身伽玛刀的MC模型模拟结果分别与对应的实验测量进行对比,不同准直器条件下,剂量分布半高宽偏差均≤1 mm,MC模拟的输出因子和厂商数据对比,偏差均在±4%之内,并进一步对偏差进行了分析.结论:动态旋转体部伽玛刀辐射剂量学MC模拟研究,基本可以为目前临床使用的不同机型体部伽玛刀的辐射剂量学质量控制提供重要参考和依据.%Objective:To study radiation dosimetry of stereotactic gamma ray radiotherapy system with dynamic rotating of different types on the same platform of Monte Carlo simulation.Methods: 1)OUR-QGD stereotactic gamma ray radiotherapy system and LUNA whole body gamma ray radiotherapy system were selected as the representative model according to the focus mode of stereotactic gamma ray radiotherapy system. 2)MC modeling were implemented based on EGSnrc, respectively. 3)The distributions of dosage at focus were detected by using EBT3 film and 160 mm mode of plexiglass sphere so as to verify MC mode. 4)The relative research of dosimetry was implemented by using the verified mode. Results: The simulation results of the Monte Carlo model of the OUR-QGD stereotactic gamma ray radiotherapy systems and LUNA whole body gamma ray radiotherapy systems were compared with the corresponding result of experimental measurements, respectively. Under the different conditions of collimator, all of the Full Width at Half Maximum(FWHM) deviation of the dose distribution was less than or equal to 1 mm. And the result of the comparison between output factor of MC simulation and data from manufactory revealed that all of deviation were in ±4%, and the deviations were further analyzed.Conclusion: The research of Monte carlo simulation of radiation dosimetry about stereotactic gamma ray radiotherapy system with dynamic rotation can provide important reference and basis for quality control of radiation dosimetry of stereotactic gamma ray radiotherapy system of different type in clinical application at present.
    • 吴清木; 张江灵; 郑维斌; 高清龙
    • 摘要: 目的 探讨体部伽玛刀联合化疗治疗恶性肿瘤伴发上腔静脉综合征(SVCS)的疗效.方法 55例恶性肿瘤伴发SVCS采用伽玛刀联合同步化疗1周期,伽玛刀治疗结束后继续化疗4~6个周期;伽玛刀治疗处方剂量为以50%等剂量曲线包绕PTV,60%等剂量曲线包绕90%以上GTV,DT 45~54 Gy/10~12次;观察症状缓解快慢、近期疗效及远期疗效.结果 55例患者均按计划完成治疗,SVCS症状均在伽玛刀治疗期间开始缓解,无未缓解或病情进展患者,中位治疗缓解次数6次;2周内完全缓解28例(50.9%),2个月总有效率(RR)为98.2%(54/55),无进展患者.全组随访时间为1~31个月,1年生存率为72.7%(40/55),2年生存率为43.6%(24/55);0~1级急性放射性肺炎4例,0~1级急性放射性食管炎3例,1~2级骨髓抑制9例,0~2级胃肠道反应12例,脱发4例;未出现3~4级不良反应.结论 伽玛刀联合化疗治疗癌性SVCS有缓解快、有效率高、复发率低、耐受性好及副反应发生率低的特点,不失为治疗SVCS的好方法.%Objective To investigate the efficacy of the alleviative treatment of superior vena cava syndrome(SVCS) combined body-γ-knife with chemotherapy.Methods Fifty-five cases of SVCS were treated with γ-knife combined with 1 cycle chemotherapy in the.After the γ-knife treatment,the patients were received 4 to 6 cycles of chemotherapy;the 50% isodose curve was used as the prescerption isodose curve to wrap PTV,and the 60% odose curve wrapped more than 90% GTV;according to the pathological type,the total dose was 45-54 Gy for 10-12 fractions.The symptom relief rate,short-term efficacy and long-term efficacy were observed.Results All of the 55 patients were accomplished treatment according to the plan, all the symptoms of SVCS were relieved during the treatment of γ-knife and median treatment was 6 times.There was no one patient who had not been relieved.The complete remission was achieved in 28 cases (50.9%) within two weeks,the total effective rate of two months was 98.2%(54/55).There was no one patient with PD.All patients were followed up for 1-31 months.The 1-year survival rate was 72.7% (40/55), 2-year survival rate was 43.6% (24/55);4 cases of grade 0-1 grade acute radiation pneumonitis (7.2%),3 cases of grade 0-1 grade acute radiation esophagitis (5.4%),9 cases of grade 0-2 bone marrow suppression (16.3%),12 cases of grade 0-2 gastrointestinal reaction (21.8%),4 cases of alopecia (7.2%),and did not appear 3-4 grade adverse reactions.Conclusion γ-knife combined with chemotherapy in the treatment of SVCS has the characteristics of fast response,high efficiency,low recurrence rate,good tolerability and fewer side effects,therefore combined body-γ-knife with chemotherapy as therapeutic strategy is a good method to treat SVCS.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号